FIELD: medicine.
SUBSTANCE: method involves measuring systolic arterial blood pressure SABP. SABP being > 115 mm of mercury column, taste table salt sensitivity threshold TTSST being equal to 0.10±0.012% NaCl; SABP being > 118 mm of mercury column, TTSST being equal to 0.15±0.010% NaCl; SABP being > 122 mm of mercury column, TTSST being equal to 0.20±0.013% NaCl; SABP being > 126 mm of mercury column, TTSST being equal to 0.25±0.012% NaCl; SABP being > 129 mm of mercury column, TTSST being equal to 0.30±0.01% NaCl; SABP being > 132 mm of mercury column, TTSST being equal to 0.35±0.01% NaCl; SABP being > 136 mm of mercury column, TTSST being equal to 0.40±0.012% NaCl, the adolescents are to be included into arterial hypertension risk group.
EFFECT: enhanced effectiveness in reducing cardiovascular disease incidence.
1 dwg, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF ARTERIAL HYPERTENSION AND NEUROCIRCULATORY DISTONIA OF HYPERTONIC TYPE IN TEENAGERS | 2010 |
|
RU2439574C1 |
| METHOD FOR SELECTING ADOLESCENTS TO RISK GROUP OF DEVELOPING ARTERIAL HYPERTENSION | 2013 |
|
RU2528901C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR ARTERIAL HYPERTENSION AND HYPERTENSIVE NEUROCIRCULATORY DYSTONIA IN ADOLESCENTS | 2010 |
|
RU2429485C1 |
| METHOD OF PREDICTING RISK OF DEVELOPING VEGETO-VASCULAR DYSTONIA BY SYMPATHYCOTONIC TYPE IN TEENAGE BOYS | 2010 |
|
RU2439573C1 |
| DIFFERENTIAL DIAGNOSIS METHOD FOR DIAGNOSING HYPERTENSION DISEASE AT EARLY STAGE AND NEUROCIRCULATORY DYSTONIA OF HYPERTENSION TYPE | 2001 |
|
RU2184490C1 |
| METHOD OF PREDICTING LEFT VENTRICULAR HYPERTROPHY IN PATIENTS WITH HYPERTENSION | 2011 |
|
RU2456916C1 |
| HERBAL TEA FOR ADOLESCENTS SUFFERING SYMPATHICOTONIC VASOMOTOR DYSCRASIA AND DEGREE 1 AND 2 ARTERIAL HYPERTENSION | 2010 |
|
RU2457850C2 |
| METHOD OF PHARMACOTHERAPY EFFICIENCY PREDICTION IN ARTERIAL HYPERTENSION | 2007 |
|
RU2356500C1 |
| METHOD FOR ASSESSING RISK OF DEVELOPING CHRONIC KIDNEY DISEASE IN MEN WITH STAGE II HYPERTENSION | 2024 |
|
RU2822812C1 |
| HYPOTENSIVE MEDICATION FOR TREATMENT OF TEENAGERS WITH ESSENTIAL ARTERIAL HYPERTENSION | 2010 |
|
RU2438690C1 |
